Healthcare-Associated klebsiella pneumoniae carbapenemase producing K. pneumoniae bloodstream infection: The time has come

Clinical Infectious Diseases

Volumn 59, Issue 2, 2014, Pages 321-322

  Corcione, Silvia ^a,b   Cardellino, Chiara S ^a,b   Calcagno, Andrea ^a,b   Fossati, Lucina ^a,c   Costa, Cecilia ^a,b   Cavallo, Rossana ^a,c   Di Perri, Giovanni ^a,b   De Rosa, Francesco G ^a,b  

^a UNIVERSITY OF TURIN   (Italy)

^b Amedeo di Savoia Hospital   (Italy)

^c MOLINETTE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC THERAPY; APACHE; BACTERIAL COLONIZATION; BLOOD CULTURE; BLOODSTREAM INFECTION; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY FAILURE; COMORBIDITY; GASTROINTESTINAL TRACT; HOSPITALIZATION; HUMAN; KLEBSIELLA PNEUMONIAE; KLEBSIELLA PNEUMONIAE BLOODSTREAM INFECTION; KLEBSIELLA PNEUMONIAE CARBAPENEMASE PRODUCING; KLEBSIELLA PNEUMONIAE INFECTION; LETTER; LIVER DISEASE; MORTALITY; PATHOGENESIS; PRIORITY JOURNAL; ADULT; AGED; BACTEREMIA; CROSS INFECTION; ENZYMOLOGY; FEMALE; HEALTH CARE FACILITY; ISOLATION AND PURIFICATION; KLEBSIELLA INFECTIONS; MALE; MICROBIOLOGY; MIDDLE AGED; SECRETION (PROCESS); SURVIVAL;

BACTERIAL PROTEIN; BETA LACTAMASE; CARBAPENEMASE;

ADULT; AGED; BACTEREMIA; BACTERIAL PROTEINS; BETA-LACTAMASES; CROSS INFECTION; FEMALE; HEALTH FACILITIES; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; MIDDLE AGED; SURVIVAL ANALYSIS;

EID: 84903964381     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciu294     Document Type: Letter

References (8)

1. Munoz-Price LS, Poirel L, Bonomo RA. Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases. Lancet Infect Dis. 2013; 13:785-96.
2. Hirsch EB, Tam VH. Detection and treatment options for Klebsiella pneumoniae carbapenemases [KPCs]: An emerging cause of multidrug-resistant infection. J Antimicrob Chemother 2010; 65:1119-25.
3. Borer A, Saidel-Odes L, Riesenberg K. Attributable mortality rate for carbapenemresistant Klebsiella pneumoniae bacteremia. Infect Control Hosp Epidemiol 2009; 30:972-6.
4. American Thoracic Society/Infectious Diseases Society of America. Guidelines for the management of adults with hospital-Acquired, ventilator-Associated, and healthcare-Associated pneumonia. Am J Respir Crit Care Med 2005; 171:388-416.
5. European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 3.1. EUCAST, 2013. Available at: Http://www.eucast.org/clinical-breakpoints/. Accessed 10 May 2014.
6. Qureshi ZA, Paterson DL, Potoski BA. Treatment outcome of bacteremia due to KPCproducing Klebsiella pneumoniae: Superiority of combination antimicrobial regimens. Antimicrob Agents Chemother 2012; 56:2108-13.
7. Zarkotou O, Pournaras S, Tselioti P. Predictors of mortality in patients with bloodstream infections caused by KPC-producing Klebsiella pneumoniae and impact of appropriate antimicrobial treatment. Clin Microbiol Infect 2011; 17:1798-803.
8. Tumbarello M, Viale P, Viscoli C. Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemaseproducing K. pneumoniae: Importance of combination therapy. Clin Infect Dis. 2012; 55:943-50.